Clinical pharmacology

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS12
Academic Journal
Presents an abstract of the research manuscript `Long-term follow-up of children with in utero exposure to immunosuppressives,' by M.J. Rieder, J.L. McLean et al from the University of Western Ontario.


Related Articles

  • Fludarabine phosphate: A DNA synthesis inhibitor with potent immunosuppressive activity and... Goodman, Elliot R.; Fiedor, Piotr S. // American Surgeon;Jun1996, Vol. 62 Issue 6, p435 

    Fludarabine phosphate selectively eliminates normal and malignant mononuclear cells in large animals and man through the inhibition of DNA synthesis. The drug depletes mononuclear cells from culture within 24 hours of initial exposure, CD4 and CD8 T cells being more sensitive than either CD20 B...

  • Market specific. Hewitt, Allison // Pharmaceutical Executive;Mar1998, Vol. 18 Issue 3, p122 

    Features the report from Decision Resources entitled `Immunosuppressive Therapy Markets: Transplant Rejection, Psoriasis, Rheumatoid Arthritis, and Lupus' which examines the market of immunosuppressives. Other topics addressed in the report; Contact information.

  • Tacrolimus (Prograf).  // RN;Sep94, Vol. 57 Issue 9, p33 

    Provides information on Tacrolimus (Prograf), an immunosuppressant drug for the prophylaxis of organ transplant rejection. Description; Indication; Dosage and administration; Contraindication; Adverse reactions; Drug interactions; Administration to pregnant patients; Pediatric use.

  • Immunosuppressants.  // Reactions Weekly;6/12/2010, Issue 1305, p18 

    The article describes the case of 68-year-old woman with pemphigus vulgaris who experienced actinic keratosis after taking immunosuppressants cyclophosphamide and dexamethasone.

  • Immunosuppressants.  // Reactions Weekly;6/12/2010, Issue 1305, p18 

    The article describes the case of a man with a history of kidney transplantation who experienced giant warty hyperkeratosis while being treated with immunosuppressants.

  • MANAGING MYASTHENIA GRAVIS: HAVE WE BEEN OVERUSING IMMUNOSUPPRESSANTS? Pitceathy, RDS; Roberts, ME; Sussman, JD // Journal of Neurology, Neurosurgery & Psychiatry;Mar2008, Vol. 79 Issue 3, p359 

    An abstract of the article "Managing Myasthenia Gravis: Have We Been Overusing Immunosuppressants?," by M. E. Roberts, J. D. Sussman, and R. D. S. Pitceathy.

  • PO-SI-065-S.  // Physical Therapy;May1998, Vol. 78 Issue 5, pS23 

    Presents a summary of an article entitled `Rehabilitation of the Child with a Split Cord Malformation and Hemimeningomyelocele,' by B.H. Connolly and R.J. Kasser.

  • Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy. Nocaudie, Marie; Bailliez, Alban; Itti, Emmanuel; Bauters, Catherine; Wemeau, Jean-Louis; Marchandise, Xavier // European Journal of Nuclear Medicine;1999, Vol. 26 Issue 5, p511 

    Abstract. Management of thyroid-associated ophthalmopathy remains a topic of controversy. Immunosuppressive treatments have to be applied at peak disease activity and before criteria of severity develop. Expression of somatostatin receptors on activated lymphocytes allows scintigraphic imaging...

  • A case of Cogan's syndrome. Maalikjy Akkawi, N.; Mattioli, F.; Pezzini, A.; Vignolo, L.A. // Neurological Sciences;Jun2000, Vol. 21 Issue 3, p183 

    Considers the Cogan's syndrome (CS) as chronic bilateral interstitial keratitis. Symptoms of CS: Identification on the immunologic mechanisms in CS; Use of immunosuppressors in the treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics